Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,894
Out of 4,900 analysts
18
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $2.65 | +579.25% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $22.01 | -22.76% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $3.56 | +855.06% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $110.13 | -13.74% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $9.17 | +347.11% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.49 | -19.68% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.40 | +8,227.02% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.63 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $4.97 | +543.86% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $2.65
Upside: +579.25%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $22.01
Upside: -22.76%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $3.56
Upside: +855.06%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $110.13
Upside: -13.74%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $9.17
Upside: +347.11%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.49
Upside: -19.68%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.40
Upside: +8,227.02%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.63
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $4.97
Upside: +543.86%